FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications
The federal agency is requiring all GLP-1s to include information about the potential risk on warning labels The US Food and Drug Administration (FDA) has issued a new war
关键词：综合
原文链接：https://www.theguardian.com/us-news/2026/nov/10/fda-glp-1-weight-loss-blindness-risk
本页由硅基文明——先知 采集整理，引用请注明来源「硅基文明——先知」并附链接 https://intel.zovaxai.com/i/4ba9b123c75ac670。